
pmid: 11552139
Cerebrovascular accidents (CVAs), or strokes, are a leading cause of disability in the United States. CVAs rank third to cardiovascular disease and cancer as a cause of death. CVAs are of 2 general types: 80% are ischemic in origin, and the remainder are hemorrhagic. Ischemic strokes may be embolic or thrombotic and involve small vessels or large vessels (primarily the carotid, vertebral, or middle cerebral arteries). It is estimated that each year, 600,000 Americans will have a CVA, and of these, 160,000 will be fatal. Of those who survive, the associated disability is often significant, and an estimated $50 billion per annum is spent on stroke care. Recent advancements in all aspects of care, including primary prevention, diagnosis, and management, have had an impact on the long-term prognosis of these patients. This article will highlight recent developments in overall stroke management and their impact on the dental and the surgical management of the stroke patient. PRIMARY PREVENTION The focus of primary stroke prevention is recognition and effective treatment of the known associated risk factors for CVAs. These include the following: hypertension, diabetes mellitus, smoking, hypercholesterolemia, and various cardiac abnormalities. Additional possible risk factors include alcoholism, use of oral contraceptives, and various hematologic (hypercoagulability) and metabolic abnormalities (Table I). Hypertension is the most important and modifiable risk factor. Both elevated systolic and diastolic pressure
Carotid Artery Diseases, Diagnostic Imaging, Endarterectomy, Carotid, Dental Care for Persons with Disabilities, Primary Prevention, Stroke, Cerebrovascular Disorders, Fibrinolytic Agents, Tissue Plasminogen Activator, Humans, Stents, Platelet Aggregation Inhibitors
Carotid Artery Diseases, Diagnostic Imaging, Endarterectomy, Carotid, Dental Care for Persons with Disabilities, Primary Prevention, Stroke, Cerebrovascular Disorders, Fibrinolytic Agents, Tissue Plasminogen Activator, Humans, Stents, Platelet Aggregation Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
